Xyzal (levocetirizine dihydrochloride)

Authors

  • William Abramovits MD,

    1. Baylor University Medical Center1 and the University of Texas Southwestern Medical School,2Dermatology Treatment & Research Center,3Dallas, TX; and the Sunnybrook Health Sciences Center, University of Toronto, Toronto,4 and Mediprobe Research Inc, London,5 Ontario, Canada
    Search for more papers by this author
  • and 1,2,3 Aditya Gupta MD, PhD 4,5

    1. Baylor University Medical Center1 and the University of Texas Southwestern Medical School,2Dermatology Treatment & Research Center,3Dallas, TX; and the Sunnybrook Health Sciences Center, University of Toronto, Toronto,4 and Mediprobe Research Inc, London,5 Ontario, Canada
    Search for more papers by this author

No abstract is available for this article.

Ancillary